Bariatric doctors who regularly prescribe GLP-1s share how long the worst Ozempic side effects last, and the best ways to ...

While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...

A medical expert warned of the side effects of the newly launched weight loss drug and advised that the drug should be taken ...

Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at INR 8,800 a month or four ...

Ozempic (injectable semaglutide) is a once-weekly treatment indicated as an add-on to diet and exercise for adults with uncontrolled Type 2 diabetes mellitus (T2DM).

Introducing Ozempic, a groundbreaking GLP-1 agonist now making waves in India! This innovative treatment emulates a natural ...

Consumer companies are increasingly betting on the male grooming and personal care categories. Wasted digital ad spend in ...

The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines ...

According to the statement issued by Novo Nordisk, "Ozempic is now available in India as 0.25 mg, 0.5 mg and 1 mg in FlexTouch Pen - an easy-to-use, once-weekly pen device. The multiple dosing ...

Novo Nordisk’s blockbuster diabetes drug, Ozempic, was officially launched in India on December 12. Unlike in the US and ...

Ozempic, launched by Novo Nordisk in India at $24.35 weekly, aims to tap into the growing diabetes and obesity market. Despite competition looming with patent expiration next year, the company ...